Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Lincoln Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199223-03-2015
23-03-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Kalpanaben Rajnibhai Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120-03-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Rajnibhai Gulabdas Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120-03-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shivani Bharatbhai Shah has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120-03-2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ashish Rajnibhai Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120-03-2015
Limited Review for Dec 31, 2014
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2014.13-02-2015
Outcome of Board Meeting
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2015, has approved the issue of 36,89,200 warrants convertible in to equal number of shares on preferential basis to the promoters / promoters' group and persons other than the promoters pursuant to the Securities And Exchange Board of India (Issue Of Capital And Disclosure Requirements) Regulations, 2009....13-02-2015
Financial Results for Dec 31, 2014
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended December 31, 2014.13-02-2015
Board Meeting on Feb 13, 2015
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2015, to consider issue of shares/warrants on preferential basis to promoters and /or other than promoters entitles.09-02-2015
Closure of Trading Window
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2015, to consider and approve the quarterly un-audited financial results for the aforesaid quarter.Further, the trading window will remain closed from the date of this letter and shall reopen after the expiry of 24 hours from the time of publication of the results.05-02-2015